Information updates

Do you have hay fever?

1 September 2020

With the changing of seasons from winter to spring coinciding with National Asthma Awareness Week (1-7 September 2020), this is a reminder that children and adults with hay fever (allergic rhinitis) and/or asthma should be using proven allergy and asthma treatments regularly and correctly. Airborne pollen increases from September to December in most regions, which can result in more hay fever and asthma symptoms.

Regular and correct treatment of hay fever or asthma is more important than ever in 2020, to avoid symptoms being mistaken for respiratory infections, including COVID-19, and to reduce sneezing and coughing which have the potential to spread infections.

Hay fever affects around one in five people in Australia and New Zealand. Symptoms include:

  • Runny, itchy, congested nose.
  • Irritable, itchy, watery and red eyes.
  • Sneezing and coughing.
  • Itchy ears, throat and palate.

Treating hay fever regularly and correctly is important for the following reasons:

  • To maintain good general health and prevent complications due to hay fever, including sinusitis.
  • To reduce adverse effects from hay fever, including tiredness due to poor sleep quality, impaired learning and reduced productivity.
  • To improve asthma control if you have asthma and hay fever. 
  • To reduce sneezing and coughing due to hay fever, which can spread respiratory infections, such as colds, influenza or COVID-19.

Further information:  

www.pollenforecast.com.au

www.allergy.org.au/patients/allergic-rhinitis-hay-fever-and-sinusitis

www.allergy.org.au/patients/asthma-and-allergy

www.allergy.org.au/patients/locate-a-specialist

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.